Promoting myelin repair in disorders such as multiple sclerosis and some types of leukodystrophy: Current studies;Approche expérimentale des stratégies réparatrices des maladies demyélinisantes du système nerveux central

Revue Neurologique

Volumn 163, Issue 5, 2007, Pages 523-531

  Baron Van Evercooren, A ^a   Lachapelle, F ^b   Nait Oumesmar, B ^b   Pham Dinh, D ^b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b NONE

Author keywords

Cell therapy; Endogenous remyelination; Remyelination

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; GLYCOPROTEIN; MYELIN; MYELIN ASSOCIATED GLYCOPROTEIN; OLIGODENDROCYTE MYELIN GLYCOPROTEIN; PROTEIN NOGO; UNCLASSIFIED DRUG; VERSICAN;

CELL THERAPY; CELL TRANSPLANTATION; ELECTROPHYSIOLOGY; HUMAN; LEUKODYSTROPHY; MULTIPLE SCLEROSIS; NERVE FIBER REGENERATION; NEUROBIOLOGY; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; REMYELINIZATION; REVIEW; SCHWANN CELL;

EID: 34249895895     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0035-3787(07)90459-2     Document Type: Review

References (68)

1. ALBERDI E, SANCHEZ-GOMEZ MV, TORRE I et al. (2006). Activation of kainate receptors sensitizes oligodendrocytes to complement attack. J Neurosci, 26(12): 3220-3228
2. ARNOLD DL, CHEN J. (2005). Measuring injury and repair of myelin and neurons in multiple sclerosis. Ernst Schering Res Found Workshop, 53: 173-186.
3. Bachelin C, Lachapelle F, Girard C et al. (2005). Efficient myelin repair of the macaque spinal cord by autologous grafting of Schwann cells Brain, 128(Pt 3): 540-549.
4. BARNETT SC, CHANG L. (2004). Olfactory ensheathing cells and CNS repair: going solo or in need of a friend? Trends Neurosci, 27(1): 54-60. Review.
5. BARON-VAN EVERCOOREN A, BLAKEMORE W. (2004). Remyelination through engraftment in Myelin and Diseases Ed R. Lazzarini-Elsevier Academic Press, 6: 143-162.
6. BOYD JG, DOUCETTE R, KAWAJA MD. (2005). Defining the role of olfactory ensheathing cells in facilitating axon remyelination following damage to the spinal cord. FASEB J, 19(7): 694-703. Review.
7. BUCHLI AD, SCHWAB ME. (2005). Inhibition of Nogo: a key strategy to increase regeneration, plasticity and functional recovery of the lesioned central nervous system. Ann Med, 237(8): 556-567. Review.
8. CHEN MK, GUILARTE TR. (2006). Imaging the peripheral benzodiazepine receptor response in central nervous system demyelination and remyelination. Toxicol Sci, 91(2): 532-539.
9. COMAN I, BARBIN G, CHARLES P, ZALC B, LUBETZKI C. (2005). Axonal signals in central nervous system myelination, demyelination and remyelination. J Neurol Sci, 233(1-2): 67-71.
10. CHANG A, TOURTELLOTTE WW, RUDICK R, TRAPP BD. (2002). Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. N Engl J Med, 346(3): 165-173.
11. CHARLES P, REYNOLDS R, SEILHEAN D et al. (2002). Re-expression of PSA-NCAM by demyelinated axons: an inhibitor of remyelination in multiple sclerosis? Brain, 125(Pt 9): 1972-1979.
12. CID C, ALVAREZ-CERMENO JC, SALINAS M, ALCAZAR A. (2005). Anti-heat shock protein 90beta antibodies decrease pre-oligodendrocyte population in perinatal and adult cell cultures. Implications for remyelination in multiple sclerosis. J Neurochem, 95(2): 349-360.
13. COLOGNATO H, FFRENCH-CONSTANT C, FELTRI ML. (2005). Human diseases reveal novel roles for neural laminins. Trends Neurosci, 28(9): 480-486.
14. DECKER L, LACHAPELLE F, MAGY L, PICARD-RIERA N, NAIT-OUMESMAR B, BARON-VAN EVERCOOREN A. (2005). Fibroblast growth factors in oligodendrocyte physiology and myelin repair. Ernst Schering Res Found Workshop, (53): 39-59.
15. .DUNCAN ID. (2005). Oligodendrocytes and stem cell transplantation: their potential in the treatment of leukoencephalopathies. J Inherit Metab Dis, 28(3): 357-368.
16. FONTOURA P, STEINMAN L. (2006). Nogo in multiple sclerosis: Growing roles of a growth inhibitor. J Neurol Sci, 245(1-2): 201-210.
17. DUNNING MD, KETTUNEN MI, FRENCH CONSTANT C, FRANKLIN RJ. (2006). Brindle KM. Magnetic resonance imaging of functional Schwann cell transplants labelled with magnetic microspheres. Neuroimage, 31(1): 172-180.
18. DUNNING MD, LAKATOS A, LOIZOU L et al. (2004). Superparamagnetic iron oxide-labeled Schwann cells and olfactory ensheathing cells can be traced in vivo by magnetic resonance imaging and retain functional properties after transplantation into the CNS. J Neurosci, 24(44): 9799-9810.
19. FAIRLESS R, FRAME MC, BARNETT SC. (2005). N-cadherin differentially determines Schwann cell and olfactory ensheathing cell adhesion and migration responses upon contact with astrocytes. Mol Cell Neurosci, 28(2): 253-263.
20. FAIRLESS R, BARNETT SC. (2005). Olfactory ensheathing cells: their role in central nervous system repair. Int J Biochem Cell Biol, 37(4): 693-699.
21. FOOTE AK, BLAKEMORE WF. (2005). Repopulation of oligodendrocyte progenitor cell depleted tissue in a model of chronic demyelination. Neuropathol Appl Neurobiol, 31(2): 105-114.
22. FRANKLIN RJ. (2002). Why does remyelination fail in multiple sclerosis? Nat Rev Neurosci, 3(9): 705-714.
23. FREUND P, SCHMIDLIN E, WANNIER T et al. (2006). Nogo-Aspecific antibody treatment enhances sprouting and functional recovery after cervical lesion in adult primates. Nat Med, 12(7): 790-792.
24. GIRAUDON P, VINCENT P, VUAILLAT C. (2005). T-cells in neuronal injury and repair: semaphorins and related T-cell signals. Neuromolecular Med, 7(3): 207-216.
25. GIRARD C, BEMELMANS AP, DUFOUR N et al. (2005). Grafts of brain-derived neurotrophic factor and neurotrophin 3-transduced primate Schwann cells lead to functional recovery of the demyelinated mouse spinal cord. J Neurosci, 25(35): 7924-7933.
26. GRIMPE B, PRESSMAN Y, LUPA MD et al. (2005). The role of proteoglycans in Schwann cell/astrocyte interactions and in regeneration failure at PNS/CNS interfaces. Mol Cell Neurosci, 28(1): 18-29.
27. GOLD R, LININGTON C, LASSMANN H. (2006). Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain, 129(Pt8): 1953-1971.
28. INOUE M, HONMOU O, OKA S, HOUKIN K, HASHI K, KOCSIS JD. (2003). Comparative analysis of remyelinating potential of focal and intravenous administration of autologous bone marrow cells into the rat demyelinated spinal cord. Glia, 44(2): 111-118.
29. JOHN GR, SHANKAR SL, SHAFIT-ZAGARDO B et al. (2002). Multiple sclerosis: re-expression of a developmental pathway that restricts oligodendrocyte maturation. Nat Med, 8(10): 1115-1121.
30. JURYNCZYK M, JUREWICZ A, BIELECKI B, RAINE CS, SELMAJ K. (2005). Inhibition of Notch signaling enhances tissue repair in an animal model of multiple sclerosis. J Neuroimmunol, 170(1-2): 3-10.
31. KASSMANN CM, LAPPE-SIERFKE C, BASE M et al. (2004). Inflammatory leukodystrophy caused by loss of peroxysome function in oligodendrocytes-a mouse model of adrenoleukodystrophy. Society for Neuroscience (Abstract).
32. KEIRSTEAD HS. (2005). Stem cells for the treatment of myelin loss. Trends Neurosci, 28(12): 677-683.
33. KEIRSTEAD HS, NISTOR G, BERNAL G et al. (2005). Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. J Neurosci, 25 (19): 4694-4705.
34. KERSCHENSTEINER M, STADELMANN C, BUDDEBERG BS et al. (2004). Targeting experimental autoimmune encephalomyelitis lesions to a predetermined axonal tract system allows for refined behavioural testing in an animal model of multiple sclerosis. Am J Pathol, 164(4): 1455-1469.
35. KONDO Y, WENGER DA, GALLO V, DUNCAN ID. (2005). Galactocerebrosidase-deficient oligodendrocytes maintain stable central myelin by exogenous replacement of the missing enzyme in mice. Proc Natl Acad Sci U S A, 102(51): 1870-1875.
36. KOTTER MR, LI WW, ZHAO C, FRANKLIN RJ. (2006). Myelin impairs CNS remyelination by inhibiting oligodendrocyte precursor cell differentiation. J Neurosci, 26(1): 328-332.
37. LACHAPELLE F, BACHELIN C, MOISSONNIER P et al. (2005). Failure of remyelination in the nonhuman primate optic nerve. Brain Pathol, 15(3): 198-207.
38. LACHAPELLE F, AVELLANA-ADALID V, NAIT-OUMESMAR B, BARON-VAN EVERCOOREN A. (2002). Fibroblast growth factor-2 (FGF-2) and platelet-derived growth factor AB (PDGF AB) promote adult SVZ-derived oligodendrogenesis in vivo. Mol Cell Neurosci, 20(3): 390-403.
39. LAVDAS AA, FRANCESCHINI I, DUBOIS-D ALCQ M, MATSAS R. (2006). Schwann cells genetically engineered to express PSA show enhanced migratory potential without impairment of their myelinating ability in vitro. Glia, 53(8): 868-878.
40. LEPORE AC, WALCZAK P, RAO MS, FISCHER I, BULTE JW. (2006) MR imaging of lineage-restricted neural precursors following transplantation into the adult spinal cord. Exp Neurol, 201(1): 49-59.
41. LUBETZKI C, WILLIAMS A, STANKOFF B. (2005). Promoting repair in multiple sclerosis: problems and prospects. Curr Opin Neurol, 18(3): 237-244.
42. MARTINO G, PLUCHINO S. (2006). The therapeutic potential of neural stem cells. Nat Rev Neurosci, 7 (5): 395-406.
43. MASON JL, TOEWS A, HOSTETTLER JD et al. (2004). Oligodendrocytes and progenitors become progressively depleted within chronically demyelinated lesions. Am J Pathol, 164(5): 1673-1682.
44. MASON JL, SUZUKI K, CHAPLIN DD, MATSUSHIMA GK. (2001). Interleukin-1beta promotes repair of the CNS. J Neurosci, 21(18): 7046-7052.
45. MCKENZIE IA, BIERNASKIE J, TOMA JG, MIDHA R, MILLER FD. (2006). Skin-derived precursors generate myelinating Schwann cells for the injured and dysmyelinated nervous system. J Neurosci, 26(24): 6651-6660.
46. MERKLER D, ERNSTING T, KERSCHENSTEINER M, BRUCK W, STADELMANN C. (2006). A new focal EAE model of cortical demyelination: multiple sclerosis-like lesions with rapid resolution of inflammation and extensive remyelination. Brain, 129(Pt8): 1972-1983.
47. MICHAILOV GV, SEREDA MW, BRINKMANN BG et al. (2004). Axonal neuregulin-1 regulates myelin sheath thickness. Science, 304(5671): 700-703.
48. NAIT-OUMESMAR B, DECKER L, PICARD-RIERA N, BARON-VAN EVERCOOREN A. (2005). Responses of the SVZ to demyelinating diseases. in The mammalian subventricular zone: its roles in brain development, cell replacement and disease by S. Levison Ed. Kluwer Academic/Plenum Press. Ch 10, pp 258-278.
49. NAIT-OUMESMAR B, DECKER L, LACHAPELLE F, AVELLANA-ADALID V, BACHELIN C, VAN EVERCOOREN A. (1999). Progenitor cells of the adult mouse subventricular zone proliferate, migrate and differentiate into oligodendrocytes after demyelination. Eur J Neurosci, 11(12): 4357-4366.
50. NIEHAUS A, SHI J, GRZENKOWSKI M et al. (2000). Patients with active relapsing-remitting multiple sclerosis synthesize antibodies recognizing oligodendrocyte progenitor cell surface protein: implications for remyelination. Ann Neurol, 48(3): 362-371.
51. NISTOR GI, TOTOIU MO, HAQUE N, CARPENTER MK, KEIRSTEAD HS. (2005). Human embryonic stem cells differentiate into oligodendrocytes in high purity and myelinate spinal cord transplantation. Glia, 49(3): 385-396.
52. O'LEARY MT, HINKS GL, CHARLTON HM, FRANKLIN RJ. (2002). Increasing levels of IGF-ImRNA expression using adenoviral vectors does not alter oligodendrocyte remyelination in the CNS of aged rats. Mol Cell Neurosci, 19(1): 32-42.
53. PENDERIS J, WOODRUFF RH, LAKATOS A et al. (2003). Increasing local levels of neuregulin (glial growth factor-2) by direct infusion into areas of demyelination does not alter remyelination in rat CNS. Eur J Neurosci 18(8): 2253-2264.
54. PICARD-RIERA N, DECKER L, DELARASSE C et al. (2002). Experimental autoimmune encephalomyelitis mobilizes neural progenitors from the subventricular zone to undergo oligodendrogenesis in adult mice. Proc Natl Acad Sci U S A, 99(20): 13211-13216.
55. PIRKO I, CIRIC B, GAMEZ J et al. (2004). A human antibody that promotes remyelination enters the CNS and decreases lesion load as detected by T2-weighted spinal cord MRI in a virus-induced murine model of MS. FASEB J, 18(13): 1577-1579.
56. PITT D, NAGELMEIER IE, WILSON HC, RAINE CS. (2003). Glutamate uptake by oligodendrocytes: Implications for excitotoxicity in multiple sclerosis. Neurology, 61(8): 1113-1120.
57. PLUCHINO S, ZANOTTI L, ROSSI B et al. (2005). Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism. Nature, 436(7048): 266-271.
58. QUINONES-HINOJOSA A, SANAI N, SORIANO-NAVARRO M et al. (2006). Cellular composition and cytoarchitecture of the adult human subventricular zone: a niche of neural stem cells. J Comp Neurol, 494(3): 415-434.
59. SASAKI M, BLACK JA, LANKFORD KL, TOKUNO HA, WAXMAN SG, KOCSIS JD. (2006) Molecular reconstruction of nodes of Ranvier after remyelination by transplanted olfactory ensheathing cells in the demyelinated spinal cord. J Neurosci, 26(6): 1803-1812.
60. SCHWAB JM, BRECHTEL K, MUELLER CA et al. (2006) Experimental strategies to promote spinal cord regeneration - an integrative perspective. Prog Neurobiol, 78(2): 91-116.
61. STANKOFF B, WANG Y, BOTTLAENDER M et al. (2006). Imaging of CNS myelin by positron-emission tomography. Proc Natl Acad Sci U S A, 103(24): 9304-9309.
62. STIDWORTHY MF, GENOUD S, LI WW et al. (2004). Notch1 and Jagged1 are expressed after CNS demyelination, but are not a major rate-determining factor during remyelination. Brain, 127(Pt 9): 1928-1941.
63. t'HART BA, BAUER J, BROK HP, ARMOR S. (2005). Non-human primate models of experimental autoimmune encephalomyelitis: variation on a theme. J Neuroimmunol, 168(1-2): 1-12.
64. VITRY S, BERTRAND JY, CUMANO A, DUBOIS-DALCQ M. (2003). Primordial hematopoietic stem cells generate microglia but not myelin-forming cells in a neural environment. J Neurosci, 23(33): 10724-10731.
65. WILBY MJ, MUIR EM, FOK-SEANG J, GOUR BJ, BLASCHUK OW, FAWCETT JW. (1999). N-Cadherin inhibits Schwann cell migration on astrocytes. Mol Cell Neurosci, 14(1): 66-84.
66. WINDREM MS, NUNES MC, RASHBAUM WK. (2004). Fetal and adult human oligodendrocyte progenitor cell isolates myelinate the congenitally dysmyelinated brain. Nat Med, (1): 93-7. Erratum in: Nat Med.: 209.
67. WOSIK K, RUFFINI F, ALMAZAN G, OLIVIER A, NALBANTOGLU J, ANTEL JP. (2004). Resistance of human adult oligodendrocytes to AMPA/kainate receptor-mediated glutamate injury. Brain, 127(Pt 12): 2636-2648.
68. ZHAO C, FANCY SP, MAGY L, URWIN JE, FRANKLIN RJ. (2005) Stem cells, progenitors and myelin repair. J Anat, 207(3): 251-258.